Escalon Medical (OTCMKTS:ESMC) Shares Break Above 50 Day Moving Average – Time to Sell?

Escalon Medical Corp. (OTCMKTS:ESMC – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $0.17 and traded as high as $0.17. Escalon Medical shares last traded at $0.17, with a volume of 2,000 shares traded.

Escalon Medical Trading Down 7.1%

The firm has a market capitalization of $1.26 million, a P/E ratio of 0.65 and a beta of 0.51. The company has a quick ratio of 2.21, a current ratio of 2.94 and a debt-to-equity ratio of 0.03. The business has a 50-day moving average price of $0.17 and a 200-day moving average price of $0.18.

Escalon Medical (OTCMKTS:ESMC – Get Free Report) last issued its earnings results on Tuesday, October 13th. The medical equipment provider reported $0.12 EPS for the quarter. The business had revenue of $3.86 million during the quarter. Escalon Medical had a return on equity of 65.44% and a net margin of 31.50%.

Escalon Medical Company Profile

(Get Free Report)

Escalon Medical Corp. is a medical-device company focused on products for the ophthalmic surgical market. The company develops, manufactures and markets devices and related products used by eye-care professionals, particularly in procedures involving the retina and vitreous.

Its product offerings have included ophthalmic surgical instruments, delivery systems and products used in retinal surgery, such as intraocular gases, silicone oils and other retinal tamponade materials. These products are designed to support procedures for treating retinal detachments and other serious eye conditions.

Escalon Medical has historically served ophthalmic surgeons and medical institutions through markets in the United States and internationally.

Further Reading

Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.